Extract from the Register of European Patents

EP About this file: EP2559706

EP2559706 - Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.03.2016
Database last updated on 28.03.2026
Most recent event   Tooltip18.03.2016Application deemed to be withdrawnpublished on 20.04.2016  [2016/16]
Applicant(s)For all designated states
Evec Inc.
Showa Building Odori W5 Chuo-ku
Sapporo 060-0042 / JP
For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2013/08]
Inventor(s)01 / Takada, Kenzo
c/o EVEC INC.
Showa Building
Odori W5
Chuo-ku
Sapporo, 060-0042 / JP
02 / Nakajima, Kantou
c/o EVEC INC.
Showa Building
Odori W5
Chuo-ku
Sapporo, 060-0042 / JP
03 / Kistler, Barbara
c/o Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
04 / Park, John
c/o Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
 [2013/08]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2013/08]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Application number, filing date12192975.612.11.2008
[2013/08]
Priority number, dateJP2007029494513.11.2007         Original published format: JP 2007294945
WO2008JP5247114.02.2008         Original published format: PCT/JP2008/052471
[2013/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2559706
Date:20.02.2013
Language:EN
[2013/08]
Search report(s)(Supplementary) European search report - dispatched on:EP21.12.2012
ClassificationIPC:C07K16/24, A61P11/00, A61P19/02, A61P17/06, A61P35/02, A61K39/00
[2014/29]
CPC:
C07K16/243 (EP,US); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P25/00 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P37/00 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61K2039/507 (EP,US); C07K2317/21 (EP,US); C07K2317/34 (EP,US);
C07K2317/73 (EP,US); C07K2317/76 (EP,US); C07K2317/92 (EP,US) (-)
Former IPC [2013/08]C07K16/24, A61P11/00, A61P19/02, A61P17/06, A61P35/02
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2013/08]
Extension statesBA16.11.2012
RS16.11.2012
TitleGerman:An hGM-CSF bindende monoklonale Antikörper und medizinische Zusammensetzungen damit[2013/08]
English:Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same[2013/08]
French:Anticorps monoclonaux qui se lient au hGM-CSF et compositions médicales les comprenant[2013/08]
Examination procedure16.11.2012Examination requested  [2013/08]
16.08.2013Amendment by applicant (claims and/or description)
13.12.2013Despatch of a communication from the examining division (Time limit: M06)
02.06.2014Reply to a communication from the examining division
19.06.2014Despatch of a communication from the examining division (Time limit: M06)
06.01.2015Application deemed to be withdrawn, date of legal effect  [2016/16]
27.01.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/16]
Parent application(s)   TooltipEP08848696.4  / EP2215119
Fees paidRenewal fee
16.11.2012Renewal fee patent year 03
16.11.2012Renewal fee patent year 04
16.11.2012Renewal fee patent year 05
27.11.2013Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.11.201407   M06   Not yet paid
30.11.201508   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD] WO2007092939  (MORPHOTEK INC et al.)
 [Y] WO2006111353  (MICROMET AG et al.)
 [YD] EP0265384  (SANDOZ AG et al.) [YD] 1-25 * paragraph [0184]; example 6 *
 [Y] WO2006122797  (MORPHOSYS AG et al.) [Y] 1-25 * examples 1,6 *
 [Y] WO03068924  (LUDWIG INST CANCER RES et al.) [Y] 1-25 * examples 1,4 *
by applicant  "The Cytokine Handbook", 2003, ACADEMIC PRESS
   BRATTON, D.L. ET AL.: "Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis", J. CLIN. INVEST., vol. 95, 1995, pages 211 - 218
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.